Get the full Acoustic Wave Cell Therapy company profile
Access contacts, investors, buying signals & more
Acoustic Wave Cell Therapy has raised $15.0M in a Series C round. The company, which works in cell therapy, disclosed the funding without naming its investors.
Few other details were provided about the round or the company's plans for the capital. Acoustic Wave Cell Therapy maintains a LinkedIn presence with 189 followers.
The weather is cooling but #MedTech news is hot! Let’s jump in… TCT 2026 spotlighted the hottest cardiovascular advancements, and Conor Hale did a nice job wrapping the highlights in his article this week.
Edwards Lifesciences showed TAVR’s impact in moderate aortic stenosis, Abbott shared one year data on its next generation LAA occluder, and Boston Scientific showed aspirin alone matched standard dual therapy after LAA closure, with less bleeding. Abbott and Johnson & Johnson MedTech spotlighted coronary lithotripsy, Medtronic and Recor Medical delivered renal denervation evidence, and Philips and
Icarus Robotics
Icarus is developing dexterous mobile robots to augment astronaut crews by handling routine, time-consuming, and hazardous tasks at a fraction of the cost of human labor—unlocking scalable commercial manufacturing and experimentation in space. With design partnerships already established with leading commercial space destinations and NASA, we raised $6.1M in seed funding in just 12 days from top-tier investors. We're currently preparing for our first deployment to the ISS in partnership with one of our customers for full scale testing. Our long-term vision is to become the leading space robotics company, enabling automated orbital factories and supporting lunar, Martian, and deep space exploration as the space economy rapidly expands.
$6.1M Seed
today
NewCo
NewCo Shift: A Cross-platform Publication NewCo Shift illuminates the companies, leaders, and issues driving the transition to a sustainable, positive-impact business ecosystem. In addition to the festivals, NewCo produces Shift Forum, an executive leadership conference which brings together founders, innovators, and CEOs from fast-growth start-ups and Fortune 500 leaders with an array of experts from the policy and regulation fields to discuss how business can navigate the shifting landscape of rapid technological change and regulatory uncertainty. We expand upon the conversations started at our live events through NewCo Shift, our multi-platform publication which illuminates the companies, leaders, and issues driving the transition to a sustainable, positive-impact business ecosystem. The brainchild of six-time media and tech entrepreneur John Battelle, NewCo Shift is defining a new approach to business journalism through editorial features, profiles, video, and more. It features content from notable writers and thinkers on a range of topics impacting global business today.
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Series c round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  アトミックソフトウェア (Atomic Software Inc.) | Series c | $3.8M | 4d ago |
| 2 |  Nyobolt United Kingdom | Series c | $60.0M | 5d ago |
$1.7M Seed
1 day ago
| $7.2B |
| 2y ago |
| 3 |  GRAIL United States | Unknown | $7.1B | 2y ago |
| 4 |  Illumina United States | Unknown | $7.1B | 2y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 9mo ago |
| 3 |
 TriOar Inc. |
| Series c |
| $24.6M |
| 6d ago |
| 4 | PhotonPay | Series c | $40.0M | 9d ago |
| 5 | Tokyo Artisan Intelligence | Series c | $8.1M | 12d ago |
Trusted by 200+ sales teams
See who invested in Acoustic Wave Cell Therapy and reach their contacts directly.
Start free trial
Kyulux
Recently received
Natch
Recently received
GimmeBirds
Recently received
